Endothelial Dysfunction: Impact on Epicardial Coronary Arteries and Microcirculation

ABSTRACT

This article examines the relationship between endothelial dysfunction and ``small vessel disease.'' Newer technologies have facilitated the study of this issue. Using a Doppler wire and the intracoronary administration of acetylcholine and papaverine, a difference can be made between functional and chronic-trophic disturbances of the coronary reserve. Papaverine induces smooth muscle cell-mediated vasodilation, acetylcholine induces nitric oxide (NO)-mediated vasodilation. The data revealed that endothelial dysfunction may be related to disturbances in the microcirculation. In addition to those vasomotor-related properties, other factors such as antithrombotic, antiadhesive disturbances contribute to the disturbed microcirculation. Newer techniques, such as serial positron emission tomography, may yield an even better understanding of these processes.

KEYWORD

Endothelium - endothelial dysfunction - NO - small vessel disease - Doppler technology

REFERENCES

• 1 Opherk D, Zebe H, Weihe E. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteries.  Circulation . 1981;  63 817-825
• 2 Strauer B E. Ventricular function and coronary hemodynamics in hypertensive heart disease.  Am J Cardiol . 1979;  44 999-1009
• 3 Marcus M L. The Coronary Circulation in Health and Disease.  New York: McGraw-Hill 1983: 285-306
• 4 Furchgott R F, Zawadski J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.  Nature . 1980;  288 373-376
• 5 Ignarro L J, Harbison R G, Wood K S, Kadowitz P J. Activation of purified guanylate cyclase by endothelium-derived relaxing factor from pulmonary artery and vein: stimulation by acetylcholine, bradykinin, and arachidonic acid.  J Pharmacol Exp Ther . 1986;  237 893-900
• 6 Ignarro L J, Buga G M, Wood K S, Burns R E, Chandhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.  Proc Natl Acad Sci USA . 1987;  84 9265-9269
• 7 Zeiher A M, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary flow regulation in patients with early atherosclerosis.  Circulation . 1991;  84 1984-1992
• 8 Rajagopalan S, Kurz S, Münzel T. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxide activation.  J Clin Invest . 1996;  97 1916-1923
• 9 Münzel T, Kurz S, Rajagopalan S. Hydralazine prevents nitroglycerine tolerance by inhibiting activation of a membrane-bound NADH oxidase: A new action for an old drug.  J Clin Invest . 1996;  98 1465-1470
• 10 Mancini G BJ, Henry G C, Macaya C. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease.  Circulation . 1996;  94 258-265
• 11 Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients.  Circulation . 1997;  96 1513-1519
• 12 Celermajer D S, Sorensen K E, Georgakopoulos D. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.  Circulation . 1993;  88 2149-2155
• 13 Celermajer D S, Adams M R, Clarkson P. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults.  N Engl J Med . 1996;  334 150-154
• 14 Vogel R A, Corretti M C, Plotnick C D. Effect of a single high-fat meal on endothelial function in healthy subjects.  Am J Cardiol . 1997;  79 350-354
• 15 Egashira K, Hirooka Y, Kai H. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.  Circulation . 1994;  89 2519-2524
• 16 Huggins G S, Pasternak R C, Alpert N M, Fischman A J, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reserve.  Circulation . 1998;  98 1291-1296
• 17 John S, Schleich M, Langenfeld M. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients. A randomized, placebo-controlled, double-blind study.  Circulation . 1998;  98 211-216
• 18 Treasure C B, Klein J L, Weintraub W S. Beneficial effect of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.  N Engl J Med . 1995;  332 481-487
• 19 Laufs U, La Fata V, Plutzky J, Liao I K. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors.  Circulation . 1998;  97 1129-1135
• 20 Nitzsche E V, Coi Y, Czermin J. Noninvasive quantification of myocardial blood flow in humans.  A direct comparison of the (13N) ammonia and the (15O) water techniques. Circulation . 1996;  93 2000-2006
• 21 Kelm M, Preik-Steinhoff H, Preik M, Strauer B E. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: Evidence for biochemical assessment of endothelial L-arginine-NO pathway.  Cardiovasc Res . 1999;  41 765-772